What can copper-binding measurements explain in the Semax laboratory study?
Copper-binding measurements in the Semax laboratory study provide mechanistic insight into how Semax interacts with copper ions and modulates copper-catalyzed oxidative processes in vitro. These measurements clarify Semax’s ability to chelate copper, disrupt copper-amyloid beta complexes, and reduce reactive oxygen species (ROS) production, but findings are limited to controlled laboratory settings and do not establish clinical efficacy or safety.
2026-10-01Read resource
